- Global Pharma News & Resources

PDA's Pacific Northwest Chapter to Hold Inaugural Event at Aptevo Therapeutics

PDA's Pacific Northwest Chapter to Hold Inaugural Event at Aptevo Therapeutics FDA compliance officers from Washington and Oregon to speak at kickoff reception

PR Newswire

BETHESDA, Md., Oct. 8, 2018

BETHESDA, Md., Oct. 8, 2018 /PRNewswire-PRWeb/ -- The Parenteral Drug Association (PDA) announced the formation of the Pacific Northwest Chapter, its newest chapter. The PDA Board of Directors voted to accept the chapter's charter and its board of volunteer officers at its September meeting in Washington, DC. The chapter will provide a local forum through which technical professionals in Washington, Oregon, Idaho, Alaska, and British Columbia can support the advancement of pharmaceutical and biopharmaceutical science and technology.

The Pacific Northwest Chapter will hold a kickoff and welcome reception on November 8, 2018 from 6:00 – 8:30 pm at Aptevo Therapeutics in Seattle, Wash. This inaugural event will be attended by Richard Johnson, President and CEO of PDA, who will discuss the PDA's organizational structure, mission, and role in guiding parenteral drug development. The event will also feature a keynote presentation by local FDA compliance officers, Maria Kelly-Doggett and William Millar, who will be discussing lifecycle management of parenteral drugs. Officers Kelly-Doggett and Millar will also be fielding questions and providing information on local FDA resources.

The following experts will serve as the volunteer officers for the PDA Pacific Northwest Chapter:
President: Lisa Rutter, Partner Therapeutics
President-Elect: Brian Hawkins, BioLife Solutions, Inc.
Secretary: Irene Braginskaya, Nohla Therapeutics
Treasurer: Anethra Wilson, Partner Therapeutics
Members At Large: Alireza Abazari, BioLife Solutions; Julia Hart, Aptevo Therapeutics    

About PDA – Connecting People, Science and Regulation®
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of over 10,500 members worldwide. Go to to learn more.


SOURCE Parenteral Drug Association

Editor Details

Last Updated: 08-Oct-2018